|
US4920051A
|
|
Recovery of urokinase compounds
|
|
US4929560A
|
|
Recovery of tissue plasminogen activator
|
|
US4923645A
|
|
Sustained release of encapsulated molecules
|
|
CA1297435C
|
|
Messenger rna stabilization in animal cells
|
|
WO8800237A1
|
|
Covalent membranes
|
|
EP0272315A1
|
|
Recombinant human tissue plasminogen activator composition
|
|
US4789516A
|
|
Production of sustained released system
|
|
AU6568386A
|
|
Vector and method for achieving high level expression in eukaryotic cells
|
|
JPS62122598A
|
|
Detection of sensitivity of cell to remedy
|
|
CA1265443A
|
|
Assays for chemotherapeutic agents
|
|
US4803168A
|
|
Microencapsulation with polymers
|
|
US4692284A
|
|
Method and apparatus for forming droplets and microcapsules
|
|
US4673650A
|
|
Protein harvesting system
|
|
US4690682A
|
|
Sustained release
|
|
DE3529203A1
|
|
VESSEL FOR CULTIVATING CELLS ON MICRO-CARRIERS OR IN CAPSULES
|
|
US4683092A
|
|
Capsule loading technique
|
|
IL74783D0
|
|
Interferon e
|
|
NL8500351A
|
|
Culturing cells using burn-in of gas.
|
|
AU3450684A
|
|
Encapsulating method to allow cells to function while facilitating their screening and isolation
|
|
CA1245984A
|
|
Polyionic microencapsulation
|
